Literature DB >> 8265600

Rapid solution assays for retroviral integration reactions and their use in kinetic analyses of wild-type and mutant Rous sarcoma virus integrases.

B Müller1, K S Jones, G W Merkel, A M Skalka.   

Abstract

A rapid method for quantitating products of the oligodeoxynucleotide processing reaction in vitro has been developed to facilitate enzymatic studies of the retroviral integrases. Unlike earlier procedures, this assay does not depend on polyacrylamide gel electrphoresis but separates products by batch adsorption to PEI-cellulose. A joining assay has also been modified, to facilitate measurement of the two distinct steps in the integration reaction under parallel conditions. Since these methods allow quantitation of numerous samples in a short period of time, they are especially useful for investigation of kinetic parameters and to measure the effects of possible inhibitors of integrase. These assay systems were used to examine the enzymatic activity of wild-type Rous sarcoma virus integrase and selected mutant proteins with substitutions of single conserved amino acids. In contrast to previous studies, reactions were performed under conditions of substrate excess, and rates, rather than yields of product generated after a given period of incubation, were determined. The results showed that substitutions of several highly conserved residues in what is most likely an evolutionarily conserved catalytic domain of the integrases resulted in a 4- to 10-fold decrease in the apparent rate of processing relative to wild type, under optimized standard conditions. Changing an invariant acidic residue reduced the rate by approximately 60-fold. When joining activity was determined, the relative effects of the substitutions tested generally paralleled the results with processing. However, with both wild-type and mutant integrase proteins, the linear phase of the joining reaction was preceded by what appears to be an exponential "burst" phase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8265600      PMCID: PMC48038          DOI: 10.1073/pnas.90.24.11633

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Integration of retroviral DNA.

Authors:  P O Brown
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

Review 2.  Unraveling retrovirus integration.

Authors:  D P Grandgenett; S R Mumm
Journal:  Cell       Date:  1990-01-12       Impact factor: 41.582

3.  The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro.

Authors:  R A Katz; G Merkel; J Kulkosky; J Leis; A M Skalka
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

Review 4.  HIV DNA integration: observations and interferences.

Authors:  J Kulkosky; A M Skalka
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  Structure of the termini of DNA intermediates in the integration of retroviral DNA: dependence on IN function and terminal DNA sequence.

Authors:  M J Roth; P L Schwartzberg; S P Goff
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

6.  Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein.

Authors:  P O Brown; B Bowerman; H E Varmus; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

7.  Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding.

Authors:  F D Bushman; A Engelman; I Palmer; P Wingfield; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro.

Authors:  R Craigie; T Fujiwara; F Bushman
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

9.  The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration.

Authors:  M Katzman; R A Katz; A M Skalka; J Leis
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

10.  Properties of avian sarcoma-leukosis virus pp32-related pol-endonucleases produced in Escherichia coli.

Authors:  R Terry; D A Soltis; M Katzman; D Cobrinik; J Leis; A M Skalka
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

View more
  10 in total

1.  Mutational scan of the human immunodeficiency virus type 2 integrase protein.

Authors:  F M van den Ent; A Vos; R H Plasterk
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Monoclonal antibodies against Rous sarcoma virus integrase protein exert differential effects on integrase function in vitro.

Authors:  B Müller; D Bizub-Bender; M D Andrake; K S Jones; A M Skalka
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

3.  Dissecting the role of the N-terminal domain of human immunodeficiency virus integrase by trans-complementation analysis.

Authors:  F M van den Ent; A Vos; R H Plasterk
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Subcellular localization and integration activities of rous sarcoma virus reverse transcriptase.

Authors:  Susanne Werner; Patrick Hindmarsh; Markus Napirei; Karin Vogel-Bachmayr; Birgitta M Wöhrl
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Nonspecific alcoholysis, a novel endonuclease activity of human immunodeficiency virus type 1 and other retroviral integrases.

Authors:  M Katzman; M Sudol
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

6.  Comparison of metal-dependent catalysis by HIV-1 and ASV integrase proteins using a new and rapid, moderate throughput assay for joining activity in solution.

Authors:  Mark D Andrake; Joseph Ramcharan; George Merkel; Xue Zhi Zhao; Terrence R Burke; Anna Marie Skalka
Journal:  AIDS Res Ther       Date:  2009-06-29       Impact factor: 2.250

7.  Methylphosphonodiester substitution near the conserved CA dinucleotide in the HIV LTR alters both extent of 3'-processing and choice of nucleophile by HIV-1 integrase.

Authors:  A Mazumder; M Gupta; Y Pommier
Journal:  Nucleic Acids Res       Date:  1994-10-25       Impact factor: 16.971

Review 8.  Oligonucleotide-based assays for integrase activity.

Authors:  George Merkel; Mark D Andrake; Joseph Ramcharan; Anna Marie Skalka
Journal:  Methods       Date:  2008-11-14       Impact factor: 3.608

9.  Mode of inhibition of HIV-1 Integrase by a C-terminal domain-specific monoclonal antibody.

Authors:  Joseph Ramcharan; Diana M Colleluori; George Merkel; Mark D Andrake; Anna Marie Skalka
Journal:  Retrovirology       Date:  2006-06-21       Impact factor: 4.602

Review 10.  In vitro methods for testing antiviral drugs.

Authors:  Michaela Rumlová; Tomáš Ruml
Journal:  Biotechnol Adv       Date:  2017-12-29       Impact factor: 14.227

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.